Bradken: Interim result 2013
It was a good result but the dreaded cycle still dominates the business.
CSL: Interim result 2013
CSL has produced another stellar result, with earnings per share rising 31%. This is a company that continues to pleasantly surprise.
STW Communications: Result 2012
STW has seen off a slowing local economy, and grown earnings 7% in 2012. This has been led by expansion into Asia, and new digital businesses.
Computershare: Interim result 2013
Investors looking for an improved performance from Computershare due to higher equity markets will have to wait a little longer, but this result provides a firm platform.
JB Hi-Fi: Interim result 2013
JB Hi-Fi's share price has soared following a 3% rise in profit. So are our fears about the sector unfounded? Jason Prowd argues they're not.
News Corp: Interim result 2013
Higher programming costs clipped profit growth in the second quarter. But we’re increasing our recommendation guide prices as past valuations appear increasingly conservative.
Australand: Result 2012
Australand has produced another decent result thanks to a full portfolio and rising rents, but corporate activity means it could be its last.
Newcrest: Interim result 2013
High gold prices offer no salvation for the largest gold miner in the land.
Telstra: Interim result 2013
Telstra's half-year results reflect the ongoing improvement in its business, culturally and financially, but growth will remain a challenge in the years ahead.
Cochlear: Interim result 2013
Even after recent falls, investors are pricing in a return to the glory days for Cochlear, but its interim result suggests potential customers may be more wary.
Caltex's star rises
The shares have soared more than 50% since last February’s 10-figure writedown. Greg Hoffman considers the case for filling your tank.
The 'high yield & safe' mini-portfolio
Low rates are making the returns from equities more attractive. But those returns are at risk from further economic shocks. Here are three stocks that offer good yields and safety.
ResMed's dream run continues
The provider of sleep apnoea machines and accessories hit the lights out again with today’s second-quarter result, but there should be plenty of growth to come.
Call 1300 880 160
Start a chat
Schedule a call
